BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McDermid A, Le Saux N, Grudeski E, Bettinger JA, Manguiat K, Halperin SA, Macdonald L, Déry P, Embree J, Vaudry W. Molecular characterization of rotavirus isolates from select Canadian pediatric hospitals. BMC Infect Dis. 2012;12:306. [PMID: 23153184 DOI: 10.1186/1471-2334-12-306] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Fujii Y, Doan YH, Suzuki Y, Nakagomi T, Nakagomi O, Katayama K. Study of Complete Genome Sequences of Rotavirus A Epidemics and Evolution in Japan in 2012-2014. Front Microbiol 2019;10:38. [PMID: 30766516 DOI: 10.3389/fmicb.2019.00038] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
2 Isabel S, Higgins RR, Peci A, Isabel MR, Deeks SL, Gubbay JB. Rotavirus genotypes circulating in Ontario, Canada, before and after implementation of the rotavirus immunization program. Vaccine 2018;36:2033-40. [PMID: 29526372 DOI: 10.1016/j.vaccine.2018.02.064] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
3 Fidhow AM, Samwel A, Ng'ang'a Z, Oundo J, Nyangao J, Wences A. Molecular epidemiology and associated risk factors of rotavirus infection among children < 5 yrs hospitalized for acute gastroenteritis in North Eastern, Kenya, 2012. Pan Afr Med J 2017;28:3. [PMID: 30167031 DOI: 10.11604/PAMJ.SUPP.2017.28.1.2486] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
4 Le Saux N. Recommandations sur l’utilisation du vaccin antirotavirus chez les nourrissons. Paediatrics & Child Health 2017;22:295-299. [DOI: 10.1093/pch/pxx071] [Reference Citation Analysis]
5 Le Saux N. Recommendations for the use of rotavirus vaccines in infants. Paediatr Child Health 2017;22:290-4. [PMID: 29483794 DOI: 10.1093/pch/pxx072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Sanford C, Langley JM, Halperin SA, Zelman M, Mvrvp. A universal infant rotavirus vaccine program in two delivery models: Effectiveness and adverse events following immunization. Hum Vaccin Immunother 2015;11:870-4. [PMID: 25746110 DOI: 10.1080/21645515.2015.1012028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
7 Tong Y, Lee BE, Pang XL. Rapid genotyping of human rotavirus using SYBR green real-time reverse transcription-polymerase chain reaction with melting curve analysis. World J Virology 2015; 4(4): 365-371 [PMID: 26568918 DOI: 10.5501/wjv.v4.i4.365] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Mullick S, Mandal P, Nayak MK, Ghosh S, De P, Rajendran K, Bhattacharya MK, Mitra U, Ramamurthy T, Kobayashi N, Chawla-Sarkar M. Hospital based surveillance and genetic characterization of rotavirus strains in children (<5 years) with acute gastroenteritis in Kolkata, India, revealed resurgence of G9 and G2 genotypes during 2011-2013. Vaccine 2014;32 Suppl 1:A20-8. [PMID: 25091674 DOI: 10.1016/j.vaccine.2014.03.018] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
9 Dóró R, László B, Martella V, Leshem E, Gentsch J, Parashar U, Bányai K. Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure? Infect Genet Evol 2014;28:446-61. [PMID: 25224179 DOI: 10.1016/j.meegid.2014.08.017] [Cited by in Crossref: 140] [Cited by in F6Publishing: 148] [Article Influence: 15.6] [Reference Citation Analysis]
10 Kittigul L, Panjangampatthana A, Rupprom K, Pombubpa K. Genetic diversity of rotavirus strains circulating in environmental water and bivalve shellfish in Thailand. Int J Environ Res Public Health 2014;11:1299-311. [PMID: 24469269 DOI: 10.3390/ijerph110201299] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
11 Paulke-Korinek M, Kollaritsch H, Aberle SW, Zwazl I, Schmidle-Loss B, Vécsei A, Kundi M. Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria. Vaccine 2013;31:2686-91. [PMID: 23597718 DOI: 10.1016/j.vaccine.2013.04.001] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 5.7] [Reference Citation Analysis]